During the past decade, Willowbrook Cardiovascular Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Willowbrook Cardiovascular Associates" are "Heart Failure" (1 trials) and "Optim Lead Insulation Related Adverse Events" (1 trials). Many other conditions were trialed in "Willowbrook Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Willowbrook Cardiovascular Associates" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "Willowbrook Cardiovascular Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Willowbrook Cardiovascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Willowbrook Cardiovascular Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Willowbrook Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".